Association of fish oil supplement use with preservation of brain volume and cognitive function

Alzheimer's & Dementia - Tập 11 - Trang 226-235 - 2015
Lori A. Daiello1,2, Assawin Gongvatana3, Shira Dunsiger4, Ronald A. Cohen3, Brian R. Ott1,2
1Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA
2Alzheimer's Disease and Memory Disorders Center, Rhode Island Hospital, Providence, RI, USA
3Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA
4Department of Behavior and Social Sciences, The Miriam Hospital, Providence, RI, USA

Tóm tắt

AbstractObjectiveThe aim of this study was to investigate whether the use of fish oil supplements (FOSs) is associated with concomitant reduction in cognitive decline and brain atrophy in older adults.MethodsWe conducted a retrospective cohort study to examine the relationship between FOS use during the Alzheimer's Disease Neuroimaging Initiative and indicators of cognitive decline. Older adults (229 cognitively normal individuals, 397 patients with mild cognitive impairment, and 193 patients with Alzheimer's disease) were assessed with neuropsychological tests and brain magnetic resonance imaging every 6 months. Primary outcomes included (1) global cognitive status and (2) cerebral cortex gray matter and hippocampus and ventricular volumes.ResultsFOS use during follow‐up was associated with significantly lower mean cognitive subscale of the Alzheimer's Disease Assessment Scale and higher Mini‐Mental State Examination scores among those with normal cognition. Associations between FOS use and the outcomes were observed only in APOE ε4–negative participants. FOS use during the study was also associated with less atrophy in one or more brain regions of interest.

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Alzheimer's & Dementia

Tập 11

226-235

Thông tin tác giả